ChAracterisation of ItaliaN severe uncontrolled Asthmatic patieNts Key features when receiving Benralizumab

Trial Identifier: D3250R00073
Sponsor: AstraZeneca
NCTID:: NCT04272463
Start Date: March 2020
Primary Completion Date: July 2020
Study Completion Date: July 2020

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Italy Acquaviva delle Fonti, Italy
Italy Bergamo, Italy
Italy Cassano Murge, Italy
Italy Catanzaro, Italy
Italy Firenze, Italy
Italy Foggia, Italy
Italy Garbagnate Milanese, Italy
Italy Genova, Italy
Italy Milano, Italy
Italy Monserrato, Italy
Italy Napoli, Italy
Italy Ostuni, Italy
Italy Reggio Emilia, Italy
Italy Roma, Italy
Italy Rozzano, Italy
Italy Scilla, Italy
Italy Siena, Italy
Italy Torino, Italy
Italy Treviso, Italy
Italy Verona, Italy